Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma

NCT07099547 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Carcinoma

Interventions

DRUG: ZG005
DRUG: Tislelizumab
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd